1. UK, C.R. Pancreatic cancer statistics. [cited 2018 18 Sep]; Available from: https://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/pancreatic-cancer#heading-Four.
2. Winter, J.M., et al., 1423 pancreaticoduodenectomies for pancreatic cancer: A single-institution experience. J Gastrointest Surg, 2006. 10(9): p. 1199-210; discussion 1210-1.
3. Griffin, O.M., et al., Characterising the impact of body composition change during neoadjuvant chemotherapy for pancreatic cancer. Pancreatology, 2019.
4. Sandini, M., et al., Association Between Changes in Body Composition and Neoadjuvant Treatment for Pancreatic Cancer. JAMA Surg, 2018. 153(9): p. 809-815.
5. Santilli, V., et al., Clinical definition of sarcopenia. Clin Cases Miner Bone Metab, 2014. 11(3): p. 177-80.
6. Tan, B.H., et al., Sarcopenia in an overweight or obese patient is an adverse prognostic factor in pancreatic cancer. Clin Cancer Res, 2009. 15(22): p. 6973-9.
7. Cooper, A.B., et al., Characterization of Anthropometric Changes that Occur During Neoadjuvant Therapy for Potentially Resectable Pancreatic Cancer. Ann Surg Oncol, 2015. 22(7): p. 2416-23.
8. Rollins, K.E., et al., The impact of sarcopenia and myosteatosis on outcomes of unresectable pancreatic cancer or distal cholangiocarcinoma. Clin Nutr, 2016. 35(5): p. 1103-9.
9. Peng, P., et al., Impact of sarcopenia on outcomes following resection of pancreatic adenocarcinoma. J Gastrointest Surg, 2012. 16(8): p. 1478-86.
10. Dalal, S., et al., Relationships among body mass index, longitudinal body composition alterations, and survival in patients with locally advanced pancreatic cancer receiving chemoradiation: a pilot study. J Pain Symptom Manage, 2012. 44(2): p. 181-91.
11. Sandini, M., et al., Association Between Changes in Body Composition and Neoadjuvant Treatment for Pancreatic Cancer. JAMA Surg, 2018.
12. Löhr, J.M., Pancreatic cancer should be treated as a medical emergency. BMJ, 2014. 349: p. g5261.
13. O'Reilly, D., et al., Diagnosis and management of pancreatic cancer in adults: A summary of guidelines from the UK National Institute for Health and Care Excellence. Pancreatology, 2018. 18(8): p. 962-970.
14. Takaori, K., et al., International Association of Pancreatology (IAP)/European Pancreatic Club (EPC) consensus review of guidelines for the treatment of pancreatic cancer. Pancreatology, 2016. 16(1): p. 14-27.
15. Ducreux, M., et al., Cancer of the pancreas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol, 2015. 26 Suppl 5: p. v56-68.
16. Kumar, R., et al., Multidisciplinary management of pancreatic cancer. Surg Oncol Clin N Am, 2013. 22(2): p. 265-87.
17. Kalaitzakis, E., et al., Clinicians' attitudes towards endoscopic ultrasound: a survey of four European countries. Scand J Gastroenterol, 2009. 44(1): p. 100-7.
18. Pancreatic Cancer statistics. [cited 2021 23 February 2021]; Available from: https://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/pancreatic-cancer#heading-Five.
19. Domínguez-Muñoz, J.E., et al., Impact of the treatment of pancreatic exocrine insufficiency on survival of patients with unresectable pancreatic cancer: a retrospective analysis. BMC Cancer, 2018. 18(1): p. 534.
20. Védie, A.L. and C. Neuzillet, Pancreatic cancer: Best supportive care. Presse Med, 2019. 48(3 Pt 2): p. e175-e185.
21. van Vugt, J.L., et al., A comparative study of software programmes for cross-sectional skeletal muscle and adipose tissue measurements on abdominal computed tomography scans of rectal cancer patients. J Cachexia Sarcopenia Muscle, 2017. 8(2): p. 285-297.
22. Prado, C.M., Body composition in chemotherapy: the promising role of CT scans. Curr Opin Clin Nutr Metab Care, 2013. 16(5): p. 525-33.
23. Martin, L., et al., Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index. J Clin Oncol, 2013. 31(12): p. 1539-47.
24. Montano-Loza, A.J., et al., Sarcopenic obesity and myosteatosis are associated with higher mortality in patients with cirrhosis. J Cachexia Sarcopenia Muscle, 2016. 7(2): p. 126-35.
25. Loh, K.W., et al., Unintentional weight loss is the most important indicator of malnutrition among surgical cancer patients. Neth J Med, 2012. 70(8): p. 365-9.
26. Sikkens, E.C., et al., Prospective assessment of the influence of pancreatic cancer resection on exocrine pancreatic function. Br J Surg, 2014. 101(2): p. 109-13.
27. Kondrup, J., et al., Nutritional risk screening (NRS 2002): a new method based on an analysis of controlled clinical trials. Clin Nutr, 2003. 22(3): p. 321-36.
28. Kondrup, J., et al., ESPEN guidelines for nutrition screening 2002. Clin Nutr, 2003. 22(4): p. 415-21.
29. Sorensen, J., et al., EuroOOPS: an international, multicentre study to implement nutritional risk screening and evaluate clinical outcome. Clin Nutr, 2008. 27(3): p. 340-9.
30. Tinju, J., et al., Anthropometric, biochemical, clinical and dietary assessment for malnutrition in south Indian patients with chronic pancreatitis. Trop Gastroenterol, 2010. 31(4): p. 285-90.
31. Duggan, S.N., et al., The prevalence of malnutrition and fat-soluble vitamin deficiencies in chronic pancreatitis. Nutr Clin Pract, 2014. 29(3): p. 348-54.
32. Rasmussen, H.H., et al., Nutrition in chronic pancreatitis. World J Gastroenterol, 2013. 19(42): p. 7267-75.
33. Brown, K.F., et al., The fraction of cancer attributable to modifiable risk factors in England, Wales, Scotland, Northern Ireland, and the United Kingdom in 2015. Br J Cancer, 2018. 118(8): p. 1130-1141.
34. Jalal M , W.J., Hopper A, PTU-023 Endoscopic ultrasound biopsy prior to palliative treatment for pancreatic cancer: can we prevent unnecessary procedures? 2018, GUT. p. A155-A156.
35. Perthen, J.E., et al., Intra- and interobserver variability in skeletal muscle measurements using computed tomography images. Eur J Radiol, 2018. 109: p. 142-146.
36. Kelly, C.M. and A. Shahrokni, Moving beyond Karnofsky and ECOG Performance Status Assessments with New Technologies. J Oncol, 2016. 2016: p. 6186543.
37. Kim, T.N. and K.M. Choi, Sarcopenia: definition, epidemiology, and pathophysiology. J Bone Metab, 2013. 20(1): p. 1-10.